Role of IL-8 induced angiogenesis in uveal melanoma

Investigational New Drugs

Volumn 31, Issue 5, 2013, Pages 1107-1114

  Lattanzio, Laura ^a   Tonissi, Federica ^a   Torta, Ilaria ^a   Gianello, Luca ^a   Russi, Elvio ^a   Milano, Gerard ^b   Merlano, Marco ^a   Lo Nigro, Cristiana ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Angiogenesis; IL 8; Uveal melanoma; VEGF

Indexed keywords

BEVACIZUMAB; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8; VASCULOTROPIN;

ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IRRADIATION; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; UVEA MELANOMA; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; COMBINED MODALITY THERAPY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-8; MELANOMA; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, INTERLEUKIN-8B; UVEAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884818154     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-013-0005-1     Document Type: Article

References (20)

1. Sudaka A, Susini A, Lo Nigro C, Fischel JL, Toussan N, Formento P, Tonissi F, Lattanzio L, Russi E, Etienne-Grimaldi MC, Merlano M, Milano G (2013) Combination of bevacizumab and irradiation on uveal melanoma: an in vitro and in vivo study. Invest New Drugs 31:59-65. doi: 10.1007/s10637-012-9834-6
2. Papastefanou VO, Cohen VML (2011) Uveal melanoma. J Skin Cancer 2011:573974. doi: 10.1155/2011/573974
3. Leyvraz S, Keilholz U (2012) Ocular melanoma: what's new? Curr Opin Oncol 24:162-169. doi: 10.1097/CCO.0b013e32834ff069
4. Sun Y, Tran BN, Worley LA, Delston RB, Harbour JW (2005) Functional Analysis of the p53 Pathway in Response to Ionizing Radiation in Uveal Melanoma. Invest Ophthalmol Vis Sci 46:1561-1564. doi: 10.1167/iovs.04-1362
5. Sheidow TG, Hooper PL, Crukley C, Young J, Heathcote JG (2000) Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis. Br J Ophtalmol 84:750-756. doi: 10.1136/bjo.84.7.750
6. Boyd SR, Tan DS, Bunce C, Gittos A, Neale MH, Hungerford JL, Charnock-Jones S, Cree IA (2002) Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window. Br J Ophtalmol 86:448-452
7. Crosby MB, Yang H, Gao W, Zhang L, Grossniklaus HE (2011) Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma. Br J Ophthalmol 95:112-117. doi: 10.1136/bjo.2010.182402
8. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58-62. doi: 10.1126/science.1104819
9. Hovinga KE, Stalpers LJ, van Bree C, Donker M, Verhoeff JJ, Rodermond HM, Bosch DA, van Furth WR (2005) Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines-A clue to radioresistance? J Neurooncol 74:99-103. doi: 10.1007/s11060-004-4204-7
10. Waugh DJJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14:6735-6741. doi: 10.1158/1078-0432.CCR-07-4843
11. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI (1991) Structure and functional expression of a human interleukin- 8 receptor. Science 253:1278-1280. doi: 10.1126/science.1840701
12. Singh S, Nannuru KC, Sadanandam A, Varney ML, Singh RK (2009) CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. Br J Cancer 100:1638-1646. doi: 10.1038/sj.bjc.6605055
13. Martin D, Galisteo R, Gutkind S (2009) CXCL8/IL8 stimulates Vascular Endothelial Growth Factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NfkB through the CBM (Carma3/Bcl10/Malt) complex. J Biol Chem 284:6038-6042. doi: 10.1074/jbc.C800207200
14. Huang D, Ding Y, Zhou M, Rini BI, Petillo D, Qian CN, Kahnoski N, Futreal PA, Furge KA, Teh BT (2010) Interleukin-8 mediates resistance to anti-Angiogenic agent Sunitinib in renal cell carcinoma. Cancer Res 70:1063-1071. doi: 10.1158/0008-5472
15. Nagarkatti-Gude N, Bronkhorst IH, van Duinen SG, Luyten GP, Jager MJ (2012) Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma. Invest Ophthalmol Vis Sci 53:6748-6755. doi: 10.1167/iovs.12-10123
16. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47:943-946
17. Mantovani G, Maccio A, Mura L, Massa E, Mudu MC, Mulas C et al (2000) Serum levels of leptin and proinflammatory cytokines in patients with advancedstage cancer at different sites. J Mol Med 78:554-561
18. Crohns M, Saarelainen S, Laine S, Poussa T, Alho H, Kellokumpu-Lehtinen P (2010) Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy - Association of interleukin-8 and VEGF with survival. Cytokine 50:30-36. doi: 10.1016/j.cyto.2009.11.017
19. Ono M (2008) Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 99:1501-1506. doi: 10.1111/j.1349-7006.2008.00853
20. el Filali M, van der Velden PA, Luyten GP, Jager MJ (2012) Antiangiogenic therapy in uveal melanoma. Dev Ophthalmol 49:117-136. doi: 10.1159/000329591